Atomic Fox
Dehner Distillery, DEHNER DISTILLERY, LLC — Clive, IA
Iowa
About Atomic Fox
Atomic Fox is a vodka brand produced in Iowa and registered with the Alcohol and Tobacco Tax and Trade Bureau. The spirit is bottled at a proof level between 80 and 89, falling within the standard range for vodka products in the United States market. According to TTB records, the brand received its initial label approval in 2020. The brand maintains a single product offering within its vodka line as documented in spirits retailers' databases. As a vodka produced domestically in Iowa, Atomic Fox represents the midwestern contribution to the American vodka category. The brand's registration with federal alcohol regulators confirms its compliance with TTB standards for spirit classification and labeling requirements. With its straightforward classification and single product designation, Atomic Fox operates within the conventional parameters of the vodka market segment.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Atomic Fox VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2020-05-19 | Dehner Distillery, DEHNER DISTILLERY, LLC |
Page 1 of 1
Atomic Fox at a Glance
Atomic Fox has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2020-05-19 and 2020-05-19. Produced in Iowa.
All information sourced from public TTB records.
Are you the owner or distributor of Atomic Fox?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
Dehner Distillery, Dehner Distillery, LLCRelated Brands
- Badger Claw also from Iowa
- Revelton Distilling CO. also from Iowa
- Wych Doctor also from Iowa
- Wych Dr Distilling also from Iowa
- Badger State also from Iowa
- Muscle also makes Vodka 80-89 Proof
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Svedka also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.